VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹18 Cr | ₹60 Cr | ₹58 Cr | ₹46 Cr | ₹58 Cr |
What is the latest Total Non-Current Liabilities ratio of VENUS REMEDIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹58 Cr |
| Mar2022 | ₹46 Cr |
| Mar2021 | ₹58 Cr |
How is Total Non-Current Liabilities of VENUS REMEDIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | -69.12 | |
| Mar2024 | ₹60 Cr | 2.89 | |
| Mar2023 | ₹58 Cr | 26.60 | |
| Mar2022 | ₹46 Cr | -20.94 | |
| Mar2021 | ₹58 Cr | - | |
Compare Total Non-Current Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,420.6 Cr | 3.7% | -3.2% | 303.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 3.7% |
-3.2% |
303.1% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses